Advertisement

Current Cardiology Reports

, 20:81 | Cite as

Heart Transplantation and Mechanical Circulatory Support in Adults with Congenital Heart Disease

  • John D. Serfas
  • Priyesh A. Patel
  • Richard A. Krasuski
Congenital Heart Disease (RA Krasuski, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Congenital Heart Disease

Abstract

Purpose of Review

To assess current management strategies for advanced heart failure in adults with congenital heart disease, including heart transplantation and mechanical circulatory support.

Recent Findings

Current data demonstrate that adults with CHD generally experience higher short-term mortality after heart transplantation and MCS implantation, but enjoy superior long-term survival. Such patients are nonetheless less likely to receive a transplant than non-ACHD peers due to a variety of factors, including lack of applicability of current listing criteria to HF in ACHD. MCS is underutilized in ACHD, but provides similar quality of life benefits for ACHD and non-ACHD patients alike.

Summary

Heart failure in ACHD is complex and difficult to treat, and both heart transplantation and mechanical circulatory support are often challenging to implement in this patient population. However, long-term results are encouraging, and existing data supports increasing use of MCS and transplant earlier in their disease course. Multidisciplinary care is critical to success in these complex patients.

Keywords

Adult congenital heart disease Heart transplantation Mechanical circulatory support LVAD Failing Fontan 

Notes

Compliance with Ethical Standards

Conflict of Interest

John D. Serfas, Priyesh Patel, and Richard A. Krasuski declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Gilboa SM, Devine OJ, Kucik JE, Oster ME, Riehle-Colarusso T, Nembhard WN, et al. Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010. Circulation. 2016;134(2):101–9.  https://doi.org/10.1161/CIRCULATIONAHA.115.019307.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the U.S. J Am Coll Cardiol. 2009;54(5):460–7.  https://doi.org/10.1016/j.jacc.2009.04.037.CrossRefPubMedGoogle Scholar
  3. 3.
    Lal S, Kotchetkova I, Cao J, Jackson D, Cordina R, Celermajer DS. Heart failure admissions and poor subsequent outcomes in adults with congenital heart disease. Eur J Heart Fail. 2018;20(4):812–5.  https://doi.org/10.1002/ejhf.1051.CrossRefPubMedGoogle Scholar
  4. 4.
    Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP, et al. Mortality in adult congenital heart disease. Eur Heart J. 2010;31(10):1220–9.  https://doi.org/10.1093/eurheartj/ehq032.CrossRefPubMedGoogle Scholar
  5. 5.
    •• Ross HJ, Law Y, Book WM, Broberg CS, Burchill L, Cecchin F, et al. Transplantation and mechanical circulatory support in congenital heart disease: a scientific statement from the American Heart Association. Circulation. 2016;133(8):802–20.  https://doi.org/10.1161/CIR.0000000000000353. Excellent and detailed summary of available data and AHA recommendations on the topic. PubMedGoogle Scholar
  6. 6.
    •• Alshawabkeh LI, Hu N, Carter KD, Opotowsky AR, Light-McGroary K, Cavanaugh JE, et al. Wait-list outcomes for adults with congenital heart disease listed for heart transplantation in the U.S. J Am Coll Cardiol. 2016;68(9):908–17.  https://doi.org/10.1016/j.jacc.2016.05.082. Multivariable analysis of ACHD transplant recipients in the Scientific Registry of Transplant Recipients that demonstrated an increased incidence of death or delisting due to worsening clinical status in ACHD patients listed 1A. CrossRefPubMedGoogle Scholar
  7. 7.
    Maxwell BG, Wong JK, Sheikh AY, Lee PH, Lobato RL. Heart transplantation with or without prior mechanical circulatory support in adults with congenital heart disease. Eur J Cardiothorac Surg. 2014;45(5):842–6.  https://doi.org/10.1093/ejcts/ezt498.CrossRefPubMedGoogle Scholar
  8. 8.
    Everitt MD, Donaldson AE, Stehlik J, Kaza AK, Budge D, Alharethi R, et al. Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS). J Heart Lung Transplant. 2011;30(4):395–401.  https://doi.org/10.1016/j.healun.2010.09.008.CrossRefPubMedGoogle Scholar
  9. 9.
    Burchill LJ, Edwards LB, Dipchand AI, Stehlik J, Ross HJ. Impact of adult congenital heart disease on survival and mortality after heart transplantation. J Heart Lung Transplant. 2014;33(11):1157–63.  https://doi.org/10.1016/j.healun.2014.05.007.CrossRefPubMedGoogle Scholar
  10. 10.
    •• Lund LH, Khush KK, Cherikh WS, Goldfarb S, Kucheryavaya AY, Levvey BJ, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant. 2017;36(10):1037–46.  https://doi.org/10.1016/j.healun.2017.07.019. The most up-to-date available data on transplant recipients, confirming the superior long-term survival of ACHD patients post-transplant and the increasing rate of MCS use as a bridge to transplant in the general population. CrossRefPubMedGoogle Scholar
  11. 11.
    Goldberg SW, Fisher SA, Wehman B, Mehra MR. Adults with congenital heart disease and heart transplantation: optimizing outcomes. J Heart Lung Transplant. 2014;33(9):873–7.  https://doi.org/10.1016/j.healun.2014.05.001.CrossRefPubMedGoogle Scholar
  12. 12.
    •• Cedars A, Vanderpluym C, Koehl D, Cantor R, Kutty S, Kirklin JK. An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of hospitalization, functional status, and mortality after mechanical circulatory support in adults with congenital heart disease. J Heart Lung Transplant. 2017;  https://doi.org/10.1016/j.healun.2017.11.010. Analysis of INTERMACS data demonstrating higher early mortality after MCS implantation, but similar improvements in QOL and adverse event rates as non-ACHD patients.
  13. 13.
    Irving C, Parry G, O’Sullivan J, Dark JH, Kirk R, Crossland DS, et al. Cardiac transplantation in adults with congenital heart disease. Heart. 2010;96(15):1217–22.  https://doi.org/10.1136/hrt.2009.184713.CrossRefPubMedGoogle Scholar
  14. 14.
    Krishnamurthy Y, Cooper LB, Lu D, Schroder JN, Daneshmand MA, Rogers JG, et al. Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States. J Heart Lung Transplant. 2016;35(5):619–24.  https://doi.org/10.1016/j.healun.2015.12.017.CrossRefPubMedGoogle Scholar
  15. 15.
    Lamour JM, Kanter KR, Naftel DC, Chrisant MR, Morrow WR, Clemson BS, et al. The effect of age, diagnosis, and previous surgery in children and adults undergoing heart transplantation for congenital heart disease. J Am Coll Cardiol. 2009;54(2):160–5.  https://doi.org/10.1016/j.jacc.2009.04.020.CrossRefPubMedGoogle Scholar
  16. 16.
    Karamlou T, Diggs BS, Welke K, Tibayan F, Gelow J, Guyton SW, et al. Impact of single-ventricle physiology on death after heart transplantation in adults with congenital heart disease. Ann Thorac Surg. 2012;94(4):1281–7; discussion 7-8.  https://doi.org/10.1016/j.athoracsur.2012.05.075.CrossRefPubMedGoogle Scholar
  17. 17.
    •• VanderPluym CJ, Cedars A, Eghtesady P, Maxwell BG, Gelow JM, Burchill LJ, et al. Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). J Heart Lung Transplant. 2018;37(1):89–99.  https://doi.org/10.1016/j.healun.2017.03.005. Analysis of INTERMACS data that shows that ACHD patients on LVAD support have similar mortality to non-ACHD patients on LVAD support. CrossRefPubMedGoogle Scholar
  18. 18.
    Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345(20):1435–43.  https://doi.org/10.1056/NEJMoa012175.CrossRefPubMedGoogle Scholar
  19. 19.
    Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357(9):885–96.  https://doi.org/10.1056/NEJMoa067758.CrossRefPubMedGoogle Scholar
  20. 20.
    Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, Acker MA, et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation. 2012;125(25):3191–200.  https://doi.org/10.1161/CIRCULATIONAHA.111.058412.CrossRefPubMedGoogle Scholar
  21. 21.
    Patel ND, Weiss ES, Allen JG, Russell SD, Shah AS, Vricella LA, et al. Heart transplantation for adults with congenital heart disease: analysis of the United Network for Organ Sharing database. Ann Thorac Surg. 2009;88(3):814–21; discussion 21-2.  https://doi.org/10.1016/j.athoracsur.2009.04.071.CrossRefPubMedGoogle Scholar
  22. 22.
    Davies RR, Russo MJ, Yang J, Quaegebeur JM, Mosca RS, Chen JM. Listing and transplanting adults with congenital heart disease. Circulation. 2011;123(7):759–67.  https://doi.org/10.1161/CIRCULATIONAHA.110.960260.CrossRefPubMedGoogle Scholar
  23. 23.
    George JF, Taylor DO, Blume ED, Kirklin JK, Naftel DC, Brown RN, et al. Minimizing infection and rejection death: clues acquired from 19 years of multi-institutional cardiac transplantation data. J Heart Lung Transplant. 2011;30(2):151–7.  https://doi.org/10.1016/j.healun.2010.08.029.CrossRefPubMedGoogle Scholar
  24. 24.
    Foster BJ, Dahhou M, Zhang X, Platt RW, Samuel SM, Hanley JA. Association between age and graft failure rates in young kidney transplant recipients. Transplantation. 2011;92(11):1237–43.  https://doi.org/10.1097/TP.0b013e31823411d7.CrossRefPubMedGoogle Scholar
  25. 25.
    Karamlou T, Hirsch J, Welke K, Ohye RG, Bove EL, Devaney EJ, et al. A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation. J Thorac Cardiovasc Surg. 2010;140(1):161–8.  https://doi.org/10.1016/j.jtcvs.2010.03.036.CrossRefPubMedGoogle Scholar
  26. 26.
    Murtuza B, Hermuzi A, Crossland DS, Parry G, Lord S, Hudson M, et al. Impact of mode of failure and end-organ dysfunction on the survival of adult Fontan patients undergoing cardiac transplantation. Eur J Cardiothorac Surg. 2017;51(1):135–41.  https://doi.org/10.1093/ejcts/ezw243.CrossRefPubMedGoogle Scholar
  27. 27.
    Kenny LA, DeRita F, Nassar M, Dark J, Coats L, Hasan A. Transplantation in the single ventricle population. Ann Cardiothorac Surg. 2018;7(1):152–9.  https://doi.org/10.21037/acs.2018.01.16.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Mitchell MB, Campbell DN, Ivy D, Boucek MM, Sondheimer HM, Pietra B, et al. Evidence of pulmonary vascular disease after heart transplantation for Fontan circulation failure. J Thorac Cardiovasc Surg. 2004;128(5):693–702.  https://doi.org/10.1016/j.jtcvs.2004.07.013.CrossRefPubMedGoogle Scholar
  29. 29.
    Egbe AC, Connolly HM, Miranda WR, Ammash NM, Hagler DJ. Veldtman GR et al. Hemodynamics of Fontan failure: the role of pulmonary vascular disease. Circ Heart Fail. 2017;10(12)  https://doi.org/10.1161/CIRCHEARTFAILURE.117.004515.
  30. 30.
    Krishnan US, Lamour JM, Hsu DT, Kichuk MR, Donnelly CM, Addonizio LJ. Management of aortopulmonary collaterals in children following cardiac transplantation for complex congenital heart disease. J Heart Lung Transplant. 2004;23(5):564–9.  https://doi.org/10.1016/S1053-2498(03)00305-X.CrossRefPubMedGoogle Scholar
  31. 31.
    Bernstein D, Naftel D, Chin C, Addonizio LJ, Gamberg P, Blume ED, et al. Outcome of listing for cardiac transplantation for failed Fontan: a multi-institutional study. Circulation. 2006;114(4):273–80.  https://doi.org/10.1161/CIRCULATIONAHA.105.548016.CrossRefPubMedGoogle Scholar
  32. 32.
    Dennis M, Zannino D, du Plessis K, Bullock A, Disney PJS, Radford DJ, et al. Clinical outcomes in adolescents and adults after the Fontan procedure. J Am Coll Cardiol. 2018;71(9):1009–17.  https://doi.org/10.1016/j.jacc.2017.12.054.CrossRefPubMedGoogle Scholar
  33. 33.
    Gossett JG, Almond CS, Kirk R, Zangwill S, Richmond ME, Kantor PF, et al. Outcomes of cardiac transplantation in single-ventricle patients with plastic bronchitis: a multicenter study. J Am Coll Cardiol. 2013;61(9):985–6.  https://doi.org/10.1016/j.jacc.2012.10.042.CrossRefPubMedGoogle Scholar
  34. 34.
    Daniels CJ, Bradley EA, Landzberg MJ, Aboulhosn J, Beekman RH 3rd, Book W, et al. Fontan-associated liver disease: proceedings from the American College of Cardiology Stakeholders Meeting, October 1 to 2, 2015, Washington DC. J Am Coll Cardiol. 2017;70(25):3173–94.  https://doi.org/10.1016/j.jacc.2017.10.045.CrossRefPubMedGoogle Scholar
  35. 35.
    Greenway SC, Crossland DS, Hudson M, Martin SR, Myers RP, Prieur T, et al. Fontan-associated liver disease: implications for heart transplantation. J Heart Lung Transplant. 2016;35(1):26–33.  https://doi.org/10.1016/j.healun.2015.10.015.CrossRefPubMedGoogle Scholar
  36. 36.
    • Menachem JN, Golbus JR, Molina M, Mazurek JA, Hornsby N, Atluri P, et al. Successful cardiac transplantation outcomes in patients with adult congenital heart disease. Heart. 2017;103(18):1449–54.  https://doi.org/10.1136/heartjnl-2016-310933. Single-center study reporting on a very successful ACHD transplant program. CrossRefPubMedGoogle Scholar
  37. 37.
    Reich HJ, Awad M, Ruzza A, De Robertis MA, Ramzy D, Nissen N, et al. Combined heart and liver transplantation: the Cedars-Sinai experience. Transplant Proc. 2015;47(9):2722–6.  https://doi.org/10.1016/j.transproceed.2015.07.038.CrossRefPubMedGoogle Scholar
  38. 38.
    Mori M, Vega D, Book W, Kogon BE. Heart transplantation in adults with congenital heart disease: 100% survival with operations performed by a surgeon specializing in congenital heart disease in an adult hospital. Ann Thorac Surg. 2015;99(6):2173–8.  https://doi.org/10.1016/j.athoracsur.2015.03.001.CrossRefPubMedGoogle Scholar
  39. 39.
    Gelow JM, Song HK, Weiss JB, Mudd JO, Broberg CS. Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices. J Heart Lung Transplant. 2013;32(11):1059–64.  https://doi.org/10.1016/j.healun.2013.06.024.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    • Steiner JM, Krieger EV, Stout KK, Stempien-Otero A, Mahr C, Mokadam NA, et al. Durable mechanical circulatory support in teenagers and adults with congenital heart disease: a systematic review. Int J Cardiol. 2017;245:135–40.  https://doi.org/10.1016/j.ijcard.2017.07.107. The only recent systematic review on the topic that captures many of the most relevant case reports and series. CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Joyce DL, Crow SS, John R, St Louis JD, Braunlin EA, Pyles LA, et al. Mechanical circulatory support in patients with heart failure secondary to transposition of the great arteries. J Heart Lung Transplant. 2010;29(11):1302–5.  https://doi.org/10.1016/j.healun.2010.05.030.CrossRefPubMedGoogle Scholar
  42. 42.
    Tchantchaleishvili V, Hallinan W, Schwarz KQ, Massey HT. Long-term total cardiac support in a Fontan-type circulation with HeartMate II left ventricular assist device. Interact Cardiovasc Thorac Surg. 2016;22(5):692–4.  https://doi.org/10.1093/icvts/ivw010.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Imielski BR, Niebler RA, Kindel SJ, Woods RK. HeartWare ventricular assist device implantation in patients with Fontan physiology. Artif Organs. 2017;41(1):40–6.  https://doi.org/10.1111/aor.12852.CrossRefPubMedGoogle Scholar
  44. 44.
    Pretre R, Haussler A, Bettex D, Genoni M. Right-sided univentricular cardiac assistance in a failing Fontan circulation. Ann Thorac Surg. 2008;86(3):1018–20.  https://doi.org/10.1016/j.athoracsur.2008.03.003.CrossRefPubMedGoogle Scholar
  45. 45.
    Rossano JW, Goldberg DJ, Fuller S, Ravishankar C, Montenegro LM, Gaynor JW. Successful use of the total artificial heart in the failing Fontan circulation. Ann Thorac Surg. 2014;97(4):1438–40.  https://doi.org/10.1016/j.athoracsur.2013.06.120.CrossRefPubMedGoogle Scholar
  46. 46.
    Woods RK, Ghanayem NS, Mitchell ME, Kindel S, Niebler RA. Mechanical circulatory support of the Fontan patient. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2017;20:20–7.  https://doi.org/10.1053/j.pcsu.2016.09.009.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • John D. Serfas
    • 1
  • Priyesh A. Patel
    • 1
  • Richard A. Krasuski
    • 1
  1. 1.Duke University Medical CenterDurhamUSA

Personalised recommendations